Zobrazeno 1 - 10
of 405
pro vyhledávání: '"viral variants"'
Autor:
Shao Lin, Han Liu, Quan Qi, Ian Trees, Donghong Gao, Samantha Friedman, Xiaobo Romeiko Xue, David Lawrence
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionWe described how COVID-19 fatality and symptoms varied by dominant variant and vaccination in the US.MethodsUsing the Restricted Access Dataset from the US CDC (1/1/2020–10/20/2022), we conducted a cross-sectional study assessing differ
Externí odkaz:
https://doaj.org/article/26878f96f4064fa09ada0afbcea2a97d
Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies
Autor:
Nuha Almulla, Raya Soltane, Ahlam Alasiri, Abdou Kamal Allayeh, Taha Alqadi, Fatma Alshehri, Ahlam Hamad Alrokban, Sameh S. Zaghlool, Abdallah Z. Zayan, Karam F. Abdalla, Ahmed M. Sayed
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e29909- (2024)
According to information from the World Health Organization, the world has experienced about 430 million cases of COVID-19, a world-wide health crisis caused by the SARS-CoV-2 virus. This outbreak, originating from China in 2019, has led to nearly 6
Externí odkaz:
https://doaj.org/article/b492bb42f6bd472cabd8f1fb74d1c8e6
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 13, Iss 4, Pp 678-687 (2023)
Infection with SARS-CoV-2 is a growing concern to the global well-being of the public at present. Different amino acid mutations alter the biological and epidemiological characteristics, as well as immune resistance of SARS-CoV-2. The virus-induced p
Externí odkaz:
https://doaj.org/article/574c2b1672d54d4d9139fea336161e09
Autor:
Gustavo H. Kijak, Bahar Ahani, Douglas Arbetter, Fernando Chuecos, Vancheswaran Gopalakrishnan, Jagadish Beloor, Tyler Brady, Amy Nguyen, Tiffany L. Roe, Nicolette Schuko, Tianhui Zhang, F. D. Richard Hobbs, Francisco Padilla, Elizabeth J. Kelly, Hugh Montgomery, Katie Streicher
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 12, Pp 2691-2707 (2023)
Abstract Introduction AZD7442 (tixagevimab/cilgavimab) comprises neutralising monoclonal antibodies (mAbs) that bind to distinct non-overlapping epitopes on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Viral evoluti
Externí odkaz:
https://doaj.org/article/81d8ce3337a543ba897387fe3803d1b4
Autor:
Chin-Rur Yang, Sui-Yuan Chang, Yu-Nong Gong, Chung-Guei Huang, Tsung-Hua Tung, Wei Liu, Ta-Chien Chan, Kuo-Sheng Hung, Hung-Sheng Shang, Jih-Jin Tsai, Chuan-Liang Kao, Hui-Lin Wu, Li-Yu Daisy Liu, Wan-Yu Lin, Yi-Chin Fan, Chwan-Chuen King, Chia-Chi Ku
Publikováno v:
Heliyon, Vol 9, Iss 12, Pp e22436- (2023)
Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases f
Externí odkaz:
https://doaj.org/article/513393f0f35649aca846061a3bf65b23
Autor:
Frederik Peissert, Mattia Pedotti, Riccardo Corbellari, Luca Simonelli, Raoul De Gasparo, Elia Tamagnini, Louis Plüss, Abdullah Elsayed, Mattia Matasci, Roberto De Luca, Irene Cassaniti, Jose’ Camilla Sammartino, Antonio Piralla, Fausto Baldanti, Dario Neri, Luca Varani
Publikováno v:
Global Challenges, Vol 7, Iss 10, Pp n/a-n/a (2023)
Abstract Neutralizing monoclonal antibodies have achieved great efficacy and safety for the treatment of numerous infectious diseases. However, their neutralization potency is often rapidly lost when the target antigen mutates. Instead of isolating n
Externí odkaz:
https://doaj.org/article/9593fd1955cb41539ee907e8cc2b1f1c
Autor:
Matthias Hillenbrand, Christoph Esslinger, Jemima Seidenberg, Marcel Weber, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos A. Guzman, Karsten Fischer, Simone Schmitt
Publikováno v:
Viruses, Vol 16, Iss 3, p 339 (2024)
As the COVID-19 pandemic revealed, rapid development of vaccines and therapeutic antibodies are crucial to guarantee a quick return to the status quo of society. In early 2020, we deployed our droplet microfluidic single-cell-based platform DROPZYLLA
Externí odkaz:
https://doaj.org/article/f5996f97c9504b889504d3692c4218f8
Autor:
Susanna Esposito, Michela Deolmi, Greta Ramundo, Matteo Puntoni, Caterina Caminiti, Nicola Principi
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Contrary to what is true for adults, little is known about pediatric long COVID (LC). Studies enrolling children are relatively few and extremely heterogeneous. This does not allow to draw definitive conclusions on the frequency and pathogenesis of p
Externí odkaz:
https://doaj.org/article/61cc403be1bf485a91051ee4cfa3348b
Autor:
Ivaylo Alexiev, Ivan Ivanov, Ivan Stoikov, Deyan Donchev, Lyubomira Grigorova, Reneta Dimitrova, Anna Gancheva, Neli Korsun, Ivelina Trifonova, Veselin Dobrinov, Todor Kantardjiev, Iva Christova
Publikováno v:
Problems of Infectious and Parasitic Diseases, Vol 50, Iss 3 (2023)
Background. Evolution of the emerging SARS-CoV-2 variants raises concerns about the possibility of accelerated transmission, disease severity, diagnostic challenges, and reduced vaccine effectiveness in the ever-evolving COVID-19 pandemic worldwide.
Externí odkaz:
https://doaj.org/article/230eabc384cd48bcb4052db00c7ae273
Autor:
Mark V. Sullivan, Francia Allabush, Harriet Flynn, Banushan Balansethupathy, Joseph A. Reed, Edward T. Barnes, Callum Robson, Phoebe O'Hara, Laura J. Milburn, David Bunka, Arron Tolley, Paula M. Mendes, James H. R. Tucker, Nicholas W. Turner
Publikováno v:
Global Challenges, Vol 7, Iss 6, Pp n/a-n/a (2023)
Abstract Virus recognition has been driven to the forefront of molecular recognition research due to the COVID‐19 pandemic. Development of highly sensitive recognition elements, both natural and synthetic is critical to facing such a global issue.
Externí odkaz:
https://doaj.org/article/2a0375f63de148749f917e9144de332f